Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2018 Jun 8;293(31):12011–12025. doi: 10.1074/jbc.RA118.002174

Structural analysis and immunostimulatory potency of lipoteichoic acids isolated from three Streptococcus suis serotype 2 strains

Nicolas Gisch ‡,1,2, Jean-Philippe Auger §,1, Simone Thomsen , David Roy §, Jianguo Xu , Dominik Schwudke ‡,3, Marcelo Gottschalk §,3
PMCID: PMC6078451  PMID: 29884769

Abstract

Streptococcus suis serotype 2 is an important porcine and human pathogen. Lipoteichoic acid (LTA) from S. suis has been suggested to contribute to its virulence, and absence of d-alanylation from the S. suis LTA is associated with increased susceptibility to cationic antimicrobial peptides. Here, using high-resolution NMR spectroscopy and MS analyses, we characterized the LTA structures from three S. suis serotype 2 strains differing in virulence, sequence type (ST), and geographical origin. Our analyses revealed that these strains possess–in addition to the typical type I LTA present in other streptococci–a second, mixed-type series of LTA molecules of high complexity. We observed a ST-specific difference in the incorporation of glycosyl residues into these mixed-type LTAs. We found that strains P1/7 (ST1, high virulence) and SC84 (ST7, very high virulence) can attach a 1,2-linked α-d-Glcp residue as branching substituent to an α-d-Glcp that is 1,3-linked to glycerol phosphate moieties and that is not present in strain 89-1591 (ST25, intermediate virulence). In contrast, the latter strain could glycosylate its LTA at the glycerol O-2 position, which was not observed in the other two strains. Using LTA preparations from WT strains and from mutants with an inactivated prolipoprotein diacylglyceryl transferase, resulting in deficient lipoprotein acylation, we show that S. suis LTAs alone do not induce Toll-like receptor 2–dependent pro-inflammatory mediator production from dendritic cells. In summary, our study reveals an unexpected complexity of LTAs present in three S. suis serotype 2 strains differing in genetic background and virulence.

Keywords: nuclear magnetic resonance (NMR), mass spectrometry (MS), glycolipid structure, bacteria, cell wall, bacterial virulence, host evasion, lipoprotein, lipoteichoic acid, Streptococcus suis

Introduction

Streptococcus suis serotype 2 is a Gram-positive bacterial pathogen of pigs responsible for important economic losses to the porcine industry worldwide, causing sudden death, meningitis, and a variety of other pathologies (1). Moreover, S. suis is an emerging zoonotic agent responsible for septic shock and meningitis in humans and has become a public health issue, particularly in South-East Asia (2). However, S. suis serotype 2 strains are genotypically and phenotypically heterogeneous, both in terms of geographical distribution and virulence, with different sequence types (STs),4 based on multilocus sequence typing (MLST), as described previously (3). This molecular typing technique is based on differences in the genetic sequences of conserved housekeeping genes, in which mutations are assumed to be largely neutral (4). MLST has classified the different S. suis strains into a large number of STs, based on differences in these genes, which has facilitated the understanding of its evolutionary divergence and epidemiology (3, 4). Data provided by the S. suis MLST database revealed that 701 different STs have been identified for S. suis (all serotypes combined), from a total of 1528 isolates. Serotype 2 strains (which is by far the most important serotype for both pigs and humans) belong to 111 of these 701 STs. Regardless of this elevated number, these STs can be regrouped into only a few clusters called clonal complexes (CC). As depicted in Fig. S1, ST1 is the most prevalent ST in terms of the number of isolates among serotype 2, and it is the founder of CC1. An important CC1 subgroup, founded by the ST7 (Fig. S1), has substantially grown in importance in recent years and was responsible for the 1998 and 2005 human S. suis outbreaks in China (5, 6). As such, ST1 strains, which predominate throughout Eurasia, South America, and Australia, and ST7 strains that are present in China, are genetically similar and generally virulent/highly virulent, respectively (3, 7, 8). Meanwhile, the CC25 and CC28, founded by the ST25 and ST28 respectively, rank as the second and third most important clusters (Fig. S1). In fact, the ST25 and ST28 account for 95% of North American strains isolated from clinical cases of porcine and human disease (3, 9). Although ST25 strains are of intermediate virulence, ST28 strains are considered low virulent and have been mostly associated with secondary infections and immunocompromised individuals (8, 9). Consequently, we chose ST1, ST7, and ST25 strains for our analyses because of their importance as predominant virulent S. suis serotype 2 strains, which are responsible for most porcine and human infections worldwide (3).

Besides peptidoglycan and lipoproteins (LPs), wall teichoic acids and lipoteichoic acids (LTA) are the major constituents of the Gram-positive cell wall. LTA has been suggested to contribute to the virulence of S. suis, whereas the absence of d-alanine residues from its LTA has been associated with an increased susceptibility to the action of cationic antimicrobial peptides (10). In another study (11), LPs, which are often co-purified with LTA (12, 13), were determined to be major activators of the porcine innate immune system. As of now, the detailed structure of the S. suis LTA remained elusive. In general, LTA contains a lipophilic anchor formed by diacylglycerol (DAG), which anchors these molecules to the cell membrane. The DAG is substituted with a glycosyl moiety at the O-3 position. These glycosyl moieties, as well as the attached complex backbone structures consisting of repetitive units (RUs), are highly variable between different species of Gram-positive bacteria. So far, five different types of LTA have been described, which are mainly characterized by the architecture of their RUs (polyglycerol phosphate (type I), complex glycosyl-glycerol-phosphate (type II + III), glycosyl-ribitol-phosphate (type IV), and glycosyl-phosphate (type V)-containing polymers) (14).

We describe herein the structural analysis of LTA isolated from three S. suis serotype 2 strains of different background as representatives of the most clinically and epidemiologically important STs using chemical degradations, high-resolution MS analysis, as well as one- and two-dimensional, homo- and heteronuclear NMR spectroscopy. Finally, the immunostimulatory properties of these well-characterized LTA preparations were evaluated to understand their role in the activation and modulation of the host innate immune response by S. suis.

Results

For the structural analyses, LTA preparations from the three S. suis serotype 2 strains P1/7 (ST1), SC84 (ST7), and 89-1591 (ST25), as well as from their respective Δlgt mutants, were prepared according to our previously published workflow (15). The latter strains lack the gene encoding for the lipoprotein diacylglyceryl transferase (Lgt) and are therefore deficient in lipidation of prolipoproteins (16). In a first step, we compared the 1H NMR spectra of native LTA from all three strains (Fig. 1). Spectra have been recorded in deuterated 25 mm sodium phosphate buffer, pH 5.5, at 300 K to suppress fast de-alanylation. In all three 1H NMR spectra, the typical NMR signals for polyglycerol phosphate chains of type I LTA molecules (14, 17) can be observed. Furthermore, all three strains are capable of modifying the glycerol O-2 position with alanine as indicated by the broad signal at δH 5.43–5.35 for proton H-2 of the alanine-substituted glycerol moieties, the signal at δH 4.33–4.27 for the CH group, and the doublet at δH 1.63 for the CH3 group of alanine (17). Whereas the spectra of LTA from strains P1/7 and SC84 are almost identical, the spectrum of LTA from strain 89-1591 indicates a different binding position for some of the present glycosyl residues (Fig. 1). Therefore, the detailed analysis of the latter LTA will be described separately below. Notably, the 1H NMR spectra of LTA from strains P1/7 and SC84 are virtually identical with the published 1H NMR spectrum for LTA isolated from S. suis serotype 2 strain 31533 (10).

Figure 1.

Figure 1.

1H NMR analysis of native LTA of the investigated S. suis serotype 2 strains indicates differences in the binding position of glycosyl residues. Shown are 1H NMR spectra (δH 6.0–0.0) isolated from S. suis strains P1/7 (ST1) (A), SC84 (ST7) (B), and 89-1591 (ST25) (C) recorded in deuterated 25 mm sodium phosphate buffer, pH 5.5, at 300 K. Black arrows in C indicate deviating major anomeric signals in LTA of strain 89-1591 compared with the other two spectra.

For a better characterization of the LTA structures, we generated defined part structures by hydrofluoric acid (HF) treatment, from which we obtained the respective lipid anchor and de-phosphorylated RUs. Afterward, we analyzed the interconnection of the RUs using de-O-acylated LTA, which was obtained by hydrazine treatment, using NMR and MS.

Preparation and structural analysis of the lipid anchor and LTA part structures from LTA of strains P1/7 and SC84

To elucidate the nature of the lipid anchor, we treated the isolated LTA of strains P1/7 and SC84 with 48% HF for 2 days at 4 °C according to our previously published procedure (18). This treatment cleaves all phosphodiester bonds and leads to the formation of dephosphorylated RUs as well as to the release of the glycolipid anchor from the LTA. The HF-treated LTA was applied to hydrophobic–interaction chromatography as described for the purification of intact LTA (shown for strain P1/7 in Fig. S2). Early in the gradient, the dephosphorylated RUs and other fatty acid–free part structures were eluted in fractions 6–9. To collect the lipid anchor, the later eluting UV-active fractions 26–34 were combined. The exact structure of the carbohydrate part of the glycolipid anchor of S. suis P1/7 and SC84 LTA was analyzed by NMR (Fig. S3 and Table S1) and was determined as α-d-Glcp-(1→2)-α-d-Glcp-(1→ (kojibiose). Consequently, the glycolipid anchor of S. suis P1/7 and SC84 LTA is α-d-Glcp-(1→2)-α-d-Glcp-(1→3)-DAG (kojibiose-diacylglycerol; 1a; bold numbers always refer to the structures shown in Fig. 2). Early fractions were combined, lyophilized, and subsequently submitted to gel-permeation chromatography (Bio-Gel P-10; shown for strain P1/7 in Fig. S4). As major molecule, we identified α-d-Glcp-(1→2)-α-d-Glcp-(1→1)-glycerol (2; Fig. 2) by NMR analysis (Fig. S5 and Table S2). In minor amounts, α-d-Glcp-(1→1)-glycerol (3; Fig. 2) was present as well (NMR data in Table S3). Furthermore, no further substituted glycerol (4; Fig. 2) was observed (signals marked with # in Fig. S5).

Figure 2.

Figure 2.

LTA part structures of the investigated S. suis strains. Shown is a compilation of structures of the observed glycolipid anchor 1a (LA; R = FA (fatty acids)), its de-O-acylated version 1b (A; R = H), and monomerized LTA repeats of different nature (27) isolated after HF treatment. Assignment of the different glucose moieties (Glc I, Glc II, Glc III, Glc ILA, and Glc IILA) is used throughout.

Structural analysis of hydrazine-treated LTA of strains P1/7 and SC84

Hydrazine treatment cleaves off all ester-bound residues like fatty acids and alanine and thus reduces the structural heterogeneity of LTA molecules. Therefore, the basic structural features of the LTA chain is accessible, because phosphodiester bonds remain intact (1820). In the following, the structural investigation of hydrazine-treated LTA (LTAN2H4) of S. suis strains P1/7 and SC84 by NMR is discussed. In Fig. 3, the 1H,13C-heteronuclear single quantum correlation (HSQC) NMR of LTAN2H4 of strain P1/7 is depicted as an example for both strains, because almost identical spectra were obtained. The complete NMR chemical shift data are summarized in Table 1. LTA isolated from WT strains and their respective Δlgt mutants are structurally identical, and the respective 1H NMR spectra of native LTA preparations from Δlgt mutants are depicted in Fig. S6 (for spectra of LTA preparations from WT strains see Fig. 1).

Figure 3.

Figure 3.

NMR analysis of de-O-acylated LTA of S. suis strain P1/7 (ST1). Shown is a section (δH 5.5–3.0; δC 105–50) of the 1H,13C HSQC NMR spectrum (recorded in D2O at 300 K) obtained from hydrazine-treated LTA of S. suis strain P1/7 (ST1), including assignment of signals. The corresponding NMR chemical shift data are listed in Table 1. (# indicates the anomeric signal of a tiny amount of Glc I lacking Glc II.)

TABLE 1.

1H (700.4 MHz), 13C NMR (176.1 MHz), and 31P NMR (283.5 MHz) chemical shift data (δ, ppm) (J, Hz) for S. suis strain P1/7 (ST1) LTA after hydrazine treatment (de-O-acyl LTA)

graphic file with name zbc031189079t001.jpg

* indicates nonresolved multiplet.

The MS analysis of LTAN2H4 of S. suis strains P1/7 and SC84 revealed a remarkably high diversity of LTA molecules. In total, we observed >60 different LTA moieties, which could be grouped into two major structural types. One series of molecules belonged to type I LTA with the observed de-O-acylated lipid anchor 1b (Fig. 2) with different numbers (X = 3–14) of glycerol phosphate (GroP)-repeating units. The second type of observed LTA contained, in addition, more complex RUs consisting of α-d-Glcp-(1→2)-α-d-Glcp-(1→3)-GroP (= Y). The number of GroP repeats (X) varied from 3 to 10, and 1 to 10 RUs of structure Y were present in these LTAN2H4 molecules. However, we only observed LTA molecules with 4–9 GroP moieties, which had multiple repeats (more than one repeat) of structure Y attached. In Fig. 4A, a representative mass spectrum of the LTAN2H4 of strain P1/7 is depicted. In Fig. 4B, the region of 800–2700 Da is enlarged, and peaks for observed LTAN2H4 molecules are assigned. The mass region containing molecules with higher molecular weight is shown in Fig. S7. The full list of identified LTAN2H4 molecules for S. suis strains P1/7 and SC84 is given in Table 2.

Figure 4.

Figure 4.

Molecular species distribution of de-O-acylated LTA of S. suis strain P1/7 (ST1). A, charge-deconvoluted spectrum of a representative MS analysis performed in the negative ion mode (the mass region of 2700–5300 Da has been magnified by a factor of 5). B, zoom into the region between 800 and 2700 Da, including detailed assignment for molecules consisting of the de-O-acyl glycolipid anchor A (1b; Fig. 2) and different combinations of RUs X (= GroP) and Y (= α-d-Glcp-(1→2)-α-d-Glcp-(1→3)-GroP). Details of all assigned molecular species are summarized in Table 2. Relative abundance for a spectral region was always normalized to the respective base peak. Additional information about molecular assignments for higher molecular species are depicted in Fig. S7.

Table 2.

Mass spectrometric analysis of de-O-acyl LTA of S. suis strains P1/7 (ST1) and SC84 (ST7)

Summary of calculated and observed molecular masses (Da) for LTA preparations after hydrazine treatment. For each preparation, two independent MS analyses have been performed, and the identified molecules are listed as a combined list (A = de-O-acyl glycolipid anchor (1b); RU X = GroP; RU Y = α-Glcp-(1→2)-α-d-Glcp-(1→3)-GroP). Masses observed only in one of the two replicates are written in italic type. Accuracy of the measurement is stated as Δppm; ND= not detected.

Molecule Calculated mass Strain P1/7
Strain SC84
Observed mass Accuracy Observed mass Accuracy
Da Da Δppm Da Δppm
X3A 878.162 878.163 0.5 ND
X4A 1032.165 1032.166 0.4 1032.167 1.6
X5A 1186.169 1186.169 0.0 1186.168 −0.4
X6A 1340.172 1340.171 −0.6 1340.170 −0.9
X7A 1494.175 1494.174 −0.4 1494.173 −1.0
X8A 1648.178 1648.177 −0.8 1648.176 −1.1
X9A 1802.181 1802.181 0.2 1802.181 −0.2
X10A 1956.184 1956.186 1.1 1956.186 0.8
X11A 2110.187 2110.188 0.1 2110.187 −0.1
X12A 2264.190 2264.192 0.8 2264.191 0.4
X13A 2418.193 2418.192 −0.5 2418.192 −0.7
X14A 2572.197 2572.204 2.9 ND
Y1X3A 1356.271 1356.270 −0.7 1356.270 −1.0
Y1X4A 1510.274 1510.274 −0.2 1510.273 −0.5
Y2X4A 1988.383 1988.385 0.9 1988.384 0.6
Y3X4A 2466.492 2466.494 1.1 2466.493 0.7
Y4X4A 2944.601 2944.602 0.3 2944.601 0.0
Y5X4A 3422.709 3422.707 −0.6 3422.707 −0.6
Y6X4A 3900.818 3900.818 −0.1 3900.808 −2.7
Y7X4A 4378.927 4378.929 0.4 4378.925 −0.4
Y8X4A 4857.036 4857.033 −0.6 4857.031 −1.0
Y9X4A 5335.144 ND 5335.140 −0.8
Y1X5A 1664.277 1664.276 −0.6 1664.276 −0.6
Y2X5A 2142.386 2142.389 1.5 2142.389 1.4
Y3X5A 2620.495 2620.494 −0.2 2620.494 −0.4
Y4X5A 3098.604 3098.601 −0.8 3098.600 −1.0
Y5X5A 3576.712 3576.707 −1.6 3576.708 −1.2
Y6X5A 4054.821 4054.810 −2.8 4054.808 −3.2
Y7X5A 4532.930 4532.929 −0.2 4532.928 −0.4
Y8X5A 5011.039 5011.038 −0.2 5011.035 −0.7
Y9X5A 5489.147 5489.160 2.2 5489.142 −1.1
Y1X6A 1818.280 1818.281 0.5 1818.282 1.1
Y2X6A 2296.389 2296.391 0.6 2296.390 0.3
Y3X6A 2774.498 2774.493 −1.7 2774.494 −1.6
Y4X6A 3252.607 3252.599 −2.5 3252.600 −2.2
Y5X6A 3730.716 3730.703 −3.5 3730.708 −2.1
Y6X6A 4208.824 4208.816 −1.9 4208.810 −3.4
Y7X6A 4686.933 4686.933 −0.1 4686.923 −2.0
Y8X6A 5165.042 5165.056 2.8 5165.038 −0.7
Y9X6A 5643.151 ND 5643.149 −0.3
Y10X6A 6121.259 6121.272 2.1 ND
Y1X7A 1972.284 1972.285 0.9 1972.285 0.6
Y2X7A 2450.392 2450.395 1.2 2450.394 0.7
Y3X7A 2928.501 2928.503 0.7 2928.502 0.4
Y4X7A 3406.610 3406.608 −0.4 3406.608 −0.4
Y5X7A 3884.719 3884.707 −3.0 3884.709 -.5
Y6X7A 4362.827 4362.827 −0.1 4362.829 0.3
Y7X7A 4840.936 4840.928 −1.6 4840.929 −1.6
Y8X7A 5319.045 5319.046 0.1 5319.040 −0.9
Y9X7A 5797.154 ND 5797.149 −0.7
Y10X7A 6275.262 ND 6275.257 −0.8
Y1X8A 2126.287 2126.287 0.0 2126.286 −0.3
Y2X8A 2604.395 2604.396 0.0 2604.394 −0.5
Y3X8A 3082.504 3082.502 −0.8 3082.501 −1.1
Y4X8A 3560.613 3560.604 −2.6 3560.605 −2.4
Y5X8A 4038.722 4038.717 −1.1 4038.719 −0.7
Y6X8A 4516.831 4516.829 −0.4 4516.828 −0.7
Y7X8A 4994.939 4994.947 1.6 4994.937 −0.4
Y8X8A 5473.048 ND 5473.045 −0.6
Y1X9A 2280.290 2280.291 0.7 2280.291 0.4
Y2X9A 2758.399 2758.406 2.7 ND
Y3X9A 3236.507 3236.515 2.4 3236.506 −0.5
Y4X9A 3714.616 3714.614 −0.5 3714.614 −0.6
Y5X9A 4192.725 4192.717 −2.0 4192.714 −2.6
Y6X9A 4670.834 4670.842 1.9 4670.828 −1.2
Y7X9A 5148.942 ND 5148.939 −0.6
Y1X10A 2434.293 2434.292 −0.4 2434.291 −0.9

To further investigate the order of the different RUs, we selected different molecules for MS/MS experiments. As an example, the MS/MS spectrum for LTAN2H4 with X = 5 and Y = 3 (mass = 2620.495 Da) is shown in Fig. 5. In this way, we could verify the consecutive order of the two different RU types X and Y. In Fig. 5A the complete overview of the MS/MS spectrum obtained in the negative ion mode is shown. Masses unequivocally presenting fragments occurring from a fragmentation starting from the de-O-acyl linker are labeled in blue in Fig. 5A, and the ones occurring from a fragmentation starting at the terminus are shown in red. Fragments that can exist from both cleavage directions are labeled black in Fig. 5A. In Fig. 5B, the observed fragment ions are assigned to the respective cleavage position in the molecule. A complete list of the observed fragments and their assignment is given in Table S4. Based on integration values from 1H NMR spectra of LTAN2H4, the chains of S. suis P1/7 LTA consist on average of 62% GroP (RU X), 33% RU Y, and 5% RU Y lacking Glc II. The values for LTA of S. suis SC84 are very similar: 57% GroP (RU X), 39% RU Y, and 4% RU Y lacking Glc II. As reference, the integral of H-1 of Glc ILAH 5.17) was set to 1.0. As measures for the different repeats, the following signals were used for integration: H-2 of Gro (δH 4.08–4.04) for RU X, H-1 of Glc I (δH 5.21–5.18) for RU Y, as well as H-1 of Glc I lacking Glc II (δH 4.97–4.94; marked with # in Fig. 3). Integration of signals was done in 1H NMR spectra obtained from LTAN2H4 of the WT and their respective Δlgt strains and have been averaged for the evaluation of RU ratios.

Figure 5.

Figure 5.

MS/MS analysis of de-O-acylated LTA molecule Y3X5A of S. suis strain P1/7 (ST1). As a representative molecule for this investigation, LTAN2H4 Y3X5A, with a calculated monoisotopic mass of 2620.495 Da has been chosen. A, complete MS/MS spectrum of the doubly charged precursor m/z 1309.243 is shown (the mass region of 400–1275 Da has been magnified by a factor of 20 and the mass region of 1315 to 2200 Da by a factor of 50). Fragment ions representing part structures starting from the de-O-acyl linker are labeled in blue, and fragment ions originating from the terminus are colored in red. Fragment ions that can be produced from both cleavage directions are labeled in black. B, all observed fragment ions are assigned to the linearized structure model of the LTA. The complete list of observed fragments and their assignment is given in Table S4.

Preparation and structural analysis of the lipid anchor and LTA part structures from LTA of strain 89-1591

The analysis of the lipid anchor and LTA part structures isolated from LTA of strain 89-1591 after HF treatment was done as described above. The glycolipid anchor of this strain was identified, as for the other two strains, as kojibiose-diacylglycerol (1a in Fig. 2). However, the observed molecules representing the dephosphorylated RUs of the LTA of strain 89-1591 differed significantly from the previously observed molecules. The major present molecule was identified as α-d-Glcp-(1→1),α-d-Glcp-(1→2)-glycerol (5); 3 and α-d-Glcp-(1→2)-glycerol (6) were observed as well. Besides that, small amounts of 2 (resulting from the completely de-O-acylated glycolipid anchor), 1-O-Ala-glycerol (7), as well as unbound glycerol (4; structures for all molecules are depicted in Fig. 2) and alanine are detectable in this preparation (Fig. S8). Molecule 7 is a result of the migration of the alanine moiety from O-2 to O-1 of the glycerol after phosphodiester bond cleavage (19), indicating the substitution of some Gro-P repeats with alanine on position O-2. The unbound alanine results from the decomposition of 7 during long-term NMR measurement into 4 and alanine. All NMR chemical shift data of 5, 6, and 7 (Fig. 2) are listed in Tables S5–S7.

Structural analysis of hydrazine-treated LTA of strain 89-1591

Hydrazine treatment of LTA isolated from S. suis strain 89-1591 was performed as for the other two strains. The 1H,13C HSQC NMR of LTAN2H4 of strain 89-1591 is depicted in Fig. 6; the complete NMR chemical shift data are summarized in Table 3.

Figure 6.

Figure 6.

NMR analysis of de-O-acylated LTA of S. suis strain 89-1591 (ST25). Shown is a section (δH 5.5–3.0; δC 105–50) of the 1H,13C HSQC NMR spectrum (recorded in D2O at 300 K) obtained from hydrazine-treated LTA of S. suis strain 89-1591 (ST25), including assignment of signals. The corresponding NMR chemical shift data are listed in Table 3.

TABLE 3.

1H (700.4 MHz), 13C NMR (176.1 MHz), and 31P NMR (283.5 MHz) chemical shift data (δ, ppm) (J, Hz) for S. suis strain 89-1591 (ST25) LTA after hydrazine treatment (de-O-acyl LTA)

graphic file with name zbc031189079t003.jpg

* indicates nonresolved multiplet.

The MS analysis of LTAN2H4 of S. suis strain 89-1591 (Fig. 7A) revealed an even higher diversity of LTA molecules than observed for the other two investigated strains. As before, we observed one series of molecules that belonged to type I LTA with the observed de-O-acylated lipid anchor 1b carrying different numbers (X = 4–20) of GroP repeats. In addition, more complex versions of these LTA molecules with additionally bound hexoses have also been observed. On the one hand, these can be α-d-Glcp residues 1,2-linked to GroP, which would lead to the de-phosphorylated RU molecule 6 (Fig. 2). On the other hand, these residues can be α-d-Glcp 1,3-linked to the GroP, leading to de-phosphorylated RU molecule 3 (Fig. 2). Finally, both glycosyl attachments can be present in the same RU, leading to de-phosphorylated RU molecule 5 (Fig. 2), which was the molecule with the highest abundance observed. Because of the multitude of combinatorial possibilities, especially with regard to the nonstoichiometric α-d-Glcp substituents of the glycerol O-2 position, which has the same additional mass as one glucose moiety within the LTA chain, the present LTAN2H4 molecules cannot be determined in such detail as for strains P1/7 and SC84. The mass spectrometric analysis depicted in Fig. 7A as well as two magnified sections of the spectrum (Fig. 7, B and C) show this increased complexity. The full list of identified LTAN2H4 molecules for S. suis strain 89-1591 can be found in Table S8. In total, we identified more than 165 different LTA moieties in the LTAN2H4 preparation of S. suis strain 89-1591, all of them measured with a mass deviation of ≤3.5 ppm. An evaluation of RU ratios as described above for LTAN2H4 from ST1/ST7 strains is not possible for LTAN2H4 of this strain, because the signal for H-2 of Gro has too much overlap with other signals in the 1H NMR spectra.

Figure 7.

Figure 7.

Molecular species distribution of de-O-acylated LTA of S. suis strain 89-1591 (ST25). A, charge-deconvoluted spectrum of a representative MS analysis performed in the negative ion mode (The mass region of 3000 to 6150 Da has been magnified by a factor of 5.). B and C, zoom into the regions between 1750 and 2050 Da (B) and 5135 and 5185 Da (C), including assignment of mass peaks for molecules consisting of the de-O-acyl glycolipid anchor A (1b; Fig. 2) and different numbers of GroP and Glc residues. The difference Δm = +8.05 Da corresponds to one GroP moiety less but one Glc moiety more in the overall composition. All identified molecules are listed in Table S8. Relative abundance for a spectral region was always normalized to the respective base peak.

Analysis of the fatty acid composition of S. suis LTA preparations

For the analysis of the fatty acid composition, the LTA preparations isolated from the Δlgt mutants have been used. These should give the most reliable values because most likely no other fatty acid-containing molecules are co-purified. As the most prominent fatty acid, hexadecanoic acid (16:0) was observed in all strains. Furthermore, 12:0, 14:0, 16:1, 18:0, and 18:1 have been detected. The molar ratios were determined to be 1.0/1.9/3.2/15.1/2.9/4.9 (12:0/14:0/16:1/16:0/18:1/18:0) for P1/7Δlgt LTA, 1.0/2.7/4.6/24.0/4.8/8.1 for SC84Δlgt LTA, and 1.0/1.4/3.6/15.2/6.2/6.2 for 89-1591Δlgt LTA.

Evaluation of the immunostimulatory properties of S. suis LTA preparations

The immunostimulatory properties of the different S. suis LTA preparations were characterized using murine bone marrow-derived DCs. DCs are innate immune cells known for their central role in the S. suis infection, including the production of pro-inflammatory mediators (21). The pro-inflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF), as well as the chemokines CXC motif chemokine ligand (CXCL) 1 and CC motif chemokine ligand (CCL) 3, were selected based on the fact that they are produced in important concentrations by DCs following S. suis infection (21). Significant levels of all four mediators were observed following activation of DCs with concentrations of 1, 3, 10, and 30 μg/ml native LTA preparations from the three S. suis WT strains (Fig. S9). The observed levels of these mediators were very similar for LTA preparations from the three S. suis strains (P1/7, SC84, and 89-1591). Only for CCL3 was an increased level at 30 μg/ml induced by LTA of strain 89-1591 observed. Moreover, levels of IL-6, CXCL1, TNF, and CCL3 were induced by all LTA preparations in a dose-dependent manner (Fig. S9).

LPs are often co-purified alongside LTA, and bacterial LPs of other Gram-positive pathogens are important activators of the innate immune response (22). Given the elevated levels of pro-inflammatory mediators produced by DCs following activation with the S. suis LTA preparations, the immunostimulatory properties of LTA preparations following treatment with H2O2 was evaluated. H2O2 oxidizes the thioether bond of LPs, which abolishes immunostimulatory activity of potentially co-purified LPs (13, 23). H2O2-treated LTA preparations only induced little IL-6, CXCL1, TNF, or CCL3 production following activation with 3 or 30 μg/ml, whereas nontreated LTA preparations induced significantly increased activity (Fig. 8), suggesting that co-purified LPs, but not the LTA, are important inducers of pro-inflammatory mediators by DCs, and this for all three strains of S. suis was evaluated.

Figure 8.

Figure 8.

Pro-inflammatory mediator production by DCs following activation with the different LTA preparations from S. suis strains P1/7 (ST1), SC84 (ST7), and 89-1591 (ST25). A–D, production of IL-6 (A), CXCL1 (B), TNF (C), and CCL3 (D) 24 h following activation of DCs with 3 or 30 μg/ml of the nontreated LTA preparations from WT strains, the LTA preparations from WT strains following treatment with H2O2 for 24 h (H2O2), or the LTA preparations from Lgt-deficient mutants (Δlgt). Secreted mediators were quantified by sandwich ELISA. Data represent the mean ± S.E. (n = 3). C denotes the culture medium alone; n.d., not detected. ***, p < 0.001, indicates a significant difference between the WT and H2O2 or Δlgt LTA preparations.

To specifically determine the immunostimulatory potential of the LTA molecules themselves, without additive or synergistic effects of the pro-inflammatory LPs, LTA was prepared from Lgt-deficient mutants. Lgt is required for LPs to be biologically active and recognized by TLR2 (16, 20). Accordingly, activation of DCs with LTA preparations from Lgt-deficient mutants of the three S. suis strains led to a complete abrogation of pro-inflammatory mediator production, regardless of the concentration of LTA used (p < 0.001) (Fig. 8).

Taken together, these results suggested that the co-purified LPs, but not the LTA, are the main activators of DCs when using LTA preparations from the S. suis strains P1/7, SC84, and 89-1591. Because LPs are recognized by TLR2 following dimerization with either TLR1 or TLR6, which allows us to discriminate between triacyl and diacyl motifs of LPs (24), DCs derived from WT and TLR2−/− mice were used. In accordance with the above-mentioned results, TLR2 deficiency resulted in a complete abrogation of pro-inflammatory mediator production by DCs, and this is regardless of the LTA concentration used (3, 10, or 30 μg/ml) (p < 0.001) (Fig. 9).

Figure 9.

Figure 9.

Pro-inflammatory mediator production by WT and TLR2−/− DCs following activation with the LTA preparations from the S. suis strains P1/7 (ST1), SC84 (ST7), and 89-1591 (ST25). A–D, production of IL-6 (A), CXCL1 (B), TNF (C), and CCL3 (D) 24 h following activation of DCs derived from WT or TLR2−/− mice with 3, 10, or 30 μg/ml of the LTA preparations. Secreted mediators were quantified by sandwich ELISA. Data represent the mean ± S.E. (n = 3). C, denotes the culture medium alone. ***, p < 0.001, indicates a significant difference between WT and TLR2−/− DCs.

Discussion

This study provides the first detailed structural characterization of LTA isolated from the important porcine and opportunistic human pathogen S. suis. We investigated three different serotype 2 strains: P1/7 (ST1), SC84 (ST7), and 89-1591 (ST25). In preparation for further immunological studies, we constructed the respective Δlgt mutants, which are deficient in Lgt-mediated prolipoprotein acylation (16, 22), and we analyzed their LTA as well. For all strains, the LTA isolated from Δlgt mutants had the same chemical structure as the one isolated from the respective parental WT strain.

As the glycolipid anchor, we identified in LTA of all three strains kojibiose-diacylglycerol, a glycolipid anchor that has also been found in other streptococci and closely related species like Lactococcus lactis (19, 25). When combining NMR and MS-based data, we were able to show that S. suis strains P1/7 and SC84 produce an almost identical LTA, which is most likely the same as present in S. suis serotype 2 strain 31533 (which is also an ST1 strain) as judged from a published 1H NMR (10). This is in line with the close relationship of ST1 and ST7 strains, because they both belong to the CC1 (7). Interestingly, these strains contained two different types of LTA. One series of LTA molecules represents a type I LTA carrying only polymeric GroP chains connected to the kojibiose-diacylglycerol lipid anchor, which are identical to those LTA molecules identified in L. lactis G121 (25), as well as Streptococcus uberis 233, Streptococcus dysgalactiae 2023, and Streptococcus agalactiae 0250 (19). The second series of observed LTA molecules comprises, in addition, more complex glycosyl residue-containing RUs consisting of α-d-Glcp-(1→2)-α-d-Glcp-(1→3)-GroP. Similar RU constitutions are known from type II or type III LTA molecules (14). By MS/MS experiments, we could verify the consecutive order of the two different repeating unit types in these LTA molecules. In S. suis strains P1/7 and SC84, a defined subset of LTA molecules with 3–10 GroP repeats was found to be elongated with 1–10 repeats of the more complex glycosyl residue-containing units. To the best of our knowledge this is the first example of such a regulated synthesis of a mixed-type LTA.

In S. suis strain 89-1591, LTA molecules of two different types were also observed. The type I LTA is of the same structure as the one determined in the other two strains. The RUs of the more complex LTA type consist either of α-d-Glcp residues 1,2-linked to GroP, α-d-Glcp residues 1,3-linked to the GroP, or most prominently both of these glycosyl attachments to GroP are present in the same repeat. A multitude of combinatory possibilities, especially with regard to the nonstoichiometric α-d-Glcp substituents at the glycerol O-2 positions in these LTA molecules, makes it impossible at this stage to determine whether the order of GroP repeats and more complex RUs is as regular as in strains P1/7 and SC84. The summary of the identified LTA structures considering also identified fatty acids and the presence of the possible, nonstoichiometric alanine substitution of the O-2 position of the glycerol moieties is depicted in Fig. 10. It is important to note that strain 89-1591 is the ST25 of the CC25, which is genetically distinct from strains of CC1. This strain also possesses lower virulence than ST1 and ST7 strains (9).

Figure 10.

Figure 10.

Chemical structures of LTA isolated from S. suis serotype 2 strains P1/7 (ST1), SC84 (ST7), and 89-1591 (ST25). From all three investigated strains, a type I LTA composed of kojibiose-diacylglycerol and polyglycerol phosphate chains was isolated. All strains are capable of modifying the glycerol O-2 position with alanine. Exclusively in strain 89-1591, a potential glycosylation at the glycerol O-2 position was additionally observed. In all strains, a second kind of LTA molecule has been identified, whereas ST-specific difference with regard to the incorporation of glycosyl residues into the complex mixed-type LTA has been observed. Strains P1/7 and SC84 are able to attach an 1,2-linked α-d-Glcp residue as branching substituent to the α-d-Glcp 1,3-linked to the GroP, whereas in strain 89-1591, this branching substituent is absent.

In our investigation, we showed that the pro-inflammatory potency of S. suis LTA molecules themselves is quite low when tested for pro-inflammatory mediator production from DCs. H2O2 treatment of LTA preparations as well as the use of LTA isolated from Δlgt strains lead to a complete abrogation of inflammatory activity independently of the strain, which can only be observed if LTA preparations of WT strains are used. This activation of DCs is totally TLR2-dependent and can therefore be ascribed to the LPs co-purified with the LTA. This is consistent with a study describing the LPs as the important activators of the swine innate immune system present in S. suis (11).

In summary, our study revealed an unexpected complexity of LTA molecules present in S. suis serotype 2 strains from different genetic and virulence backgrounds. In all investigated strains, two different kinds of LTA molecules have been identified, whereas an ST-specific difference with regard to the incorporation of glycosyl residues into the complex mixed-type LTA has been observed. Strains P1/7 and SC84 are able to attach an 1,2-linked α-d-Glcp residue as branching substituent to the α-d-Glcp 1,3-linked to the GroP. In strain 89-1591, an exclusive glycosylation at the glycerol O-2 position was observed. Just recently, the first enzyme required in the glycosylation process of this position in LTA of Listeria monocytogenes has been identified (26). The identification and analysis of respective homologous glycosyltransferases involved in such reactions in S. suis as well as the analysis of the impact on bacterial physiology and virulence are currently under investigation. This will further foster the recent achievements in the understanding of the biological role of teichoic acid glycosylation in Gram-positive bacteria (27).

Experimental procedures

Bacterial strains and growth

The well-characterized representative S. suis strains P1/7 (ST1; United Kingdom; pig meningitis (28)), SC84 (ST7; China; human streptococcal toxic shock-like syndrome (6)), and 89-1591 (ST25; Canada; pig septicemia/meningitis (29)) were used in this study. The different S. suis WT and mutant strains were grown as described previously in 6-liter batches (2 × 3 liters) (30) in Todd-Hewitt broth (BD Biosciences) to late logarithmic phase (A600 ≈1) and harvested by centrifugation (10,000 × g, 40 min, 4 °C). Bacteria were resuspended in citric buffer (50 mm, pH 4.7) and heat-killed (10 min, 100 °C). Cells were then stored at −80 °C and subsequently lyophilized.

Construction of the S. suis prolipoprotein diacylglyceryl transferase (Lgt) isogenic mutants

Lgt-deficient mutants for strains P1/7, SC84, and 89-1591 were constructed as described previously (31), including DNA manipulations. Deletion of genes was confirmed by PCR and sequencing. The oligonucleotide primers used for the constructions are listed in Table S9. The growth of the different Lgt-deficient mutants was determined to be similar to that of their respective WT strains (data not shown).

Extraction and isolation of LTA

LTA purification was performed as described elsewhere (15). Yields of LTA preparations from 6 liters of bacterial culture were as follows: strain P1/7, 21.2 mg; strain P1/7Δlgt, 20.9 mg; strain SC84, 20.2 mg; strain SC84Δlgt, 30.9 mg; strain 89-1591, 18.7/15.6 mg, and strain 89-1591Δlgt, 20.6 mg.

Chemical treatments of LTA

Hydrazine treatment (to yield de-O-acyl LTA) or HF treatment (to isolate the LTA glycolipid anchor and the dephosphorylated repeats) was performed following previously described procedures (18). Notably, de-O-acylated S. suis LTA has to be desalted by dialysis against water (MWCO: 500–1000 Da) instead of performing a size-exclusion chromatography. To destroy the TLR2 activity caused by potentially co-purified LPs, LTA preparations were treated with 1% H2O2 for 24 h at 37 °C followed by dialysis as described previously (23).

Quantification of fatty acids

Fatty acids were extracted and quantified from LTA preparations of the Δlgt mutant strains following our earlier described procedure (18), but with n-pentadecanoic acid (15:0; Sigma) used as an internal standard. Reported data for fatty acid ratios are the mean of two independent hydrolyses of the same LTA batch, both measured as two technical replicates. Different isoforms for unsaturated fatty acids (16:1; 18:1) are reported as one sum value.

NMR spectroscopy

Deuterated solvents were purchased from Deutero GmbH (Kastellaun, Germany). NMR spectroscopic measurements were performed in D2O or deuterated 25 mm sodium phosphate buffer (pH 5.5; to suppress fast de-alanylation) at 300 K on a Bruker AvanceIII 700 MHz (equipped with an inverse 5-mm quadruple-resonance Z-grad cryoprobe). Acetone was used as an external standard for calibration of 1H (δH = 2.225) and 13C (δC = 30.89) NMR spectra (32), and 85% of phosphoric acid was used as an external standard for calibration of 31P NMR spectra (δP = 0.00). Analysis of glycolipid 1 was performed in CD3OD, and spectra were calibrated using the residual solvent peak (δH = 3.31, δC = 49.0) (32). All data were acquired and processed by using Bruker TOPSPIN V 3.0 or higher. 1H NMR assignments were confirmed by 2D 1H,1H COSY and total correlation spectroscopy (TOCSY) experiments. 13C NMR assignments were indicated by 2D 1H,13C HSQC, based on the 1H NMR assignments. Inter-residue connectivity and further evidence for 13C assignment were obtained from 2D 1H,13C heteronuclear multiple bond correlation and 1H,13C HSQC-TOCSY. Connectivity of phosphate groups were assigned by 2D 1H,31P HMQC and 1H,31P HMQC-TOCSY.

Mass spectrometry

All mass spectrometric analyses were performed on a Q Exactive Plus (ThermoFisher Scientific, Bremen, Germany) using negative ion mode. LTA fractions were diluted to a final concentration of 0.03 mg/ml in propan-2-ol, water, 30 mm ammonium acetate (50:50:4, v/v/v), which was adjusted with acetic acid to pH 4.5. The HESI source was operated at −3 kV with a flow rate of 5 μl/ml using nitrogen as sheath gas at 5 atomic units. Survey MS1 and MS2 spectra were acquired with a resolution of 288,000 full width at half-maximum at m/z 200. MS2 analyses were performed using the Triversa Nanomate (Advion, Ithaca, NY) as ion source applying a spray voltage of −1.1 kV and back pressure of 1.0 p.s.i. Precursor ions were selected with isolation window width of 1.5 Da, and collision-induced dissociation was performed with 20 normalized collision energies. Deconvoluted spectra were computed using Xtract module of Xcalibur 3.1 software (ThermoFisher Scientific, Bremen, Germany).

Generation of bone marrow-derived DCs and cell activation

Murine bone marrow-derived DCs were generated as described previously (21) from the femur and tibia of WT (C57BL/6J) or TLR2−/− (B6.129-Tlr2tmKir/J) mice. Prior to activation, cells were seeded at 1 × 106 cells/ml, and different concentrations of the LTA preparations or cell culture medium alone (negative control) were added. Cell supernatants were collected 24 h later for quantification of secreted IL-6, TNF, CXCL1, and CCL3 by sandwich ELISA using pair-matched antibodies (R&D Systems).

Statistical analyses

Normality of data were verified using the Shapiro-Wilk test. Accordingly, parametric (unpaired t test) or nonparametric tests (Mann-Whitney rank sum test), where appropriate, were performed to evaluate statistical differences between groups. p < 0.05 was considered statistically significant. As software, GraphPad Prism 6 was used.

Author contributions

N. G., J.-P. A., D. S., and M. G. conceptualization; N. G., D. R., J. X., D. S., and M. G. resources; N. G., D. S., and M. G. supervision; N. G., J.-P. A., S. T., D. R., and D. S. investigation; N. G. and J.-P. A. writing-original draft; N. G. and M. G. project administration; N. G., J.-P. A., D. S., and M. G. writing-review and editing.

Supplementary Material

Supporting Information

Acknowledgments

We gratefully acknowledge B. Buske, H. Kässner, and B. Kunz (all at Research Center Borstel, Borstel, Germany) as well as S. Lacouture and C. Duquette (University of Montreal, Quebec, Canada) for excellent technical assistance. This publication made use of the Multilocus Sequence Typing Website (http://www.mlst.net) (Please note that the JBC is not responsible for the long-term archiving and maintenance of this site or any other third party hosted site.) at Imperial College London developed by D. Aanensen and funded by the Wellcome Trust.

The authors declare that they have no conflicts of interest with the contents of this article.

This article contains Figs. S1–S9 and Tables S1–S9.

4
The abbreviations used are:
ST
sequence type
CC
clonal complex
CCL
C-C motif chemokine ligand
CXCL
CXC motif chemokine ligand
DAG
diacylglycerol
DC
dendritic cell
Gro
glycerol
HF
hydrofluoric acid
HMQC
heteronuclear multiple quantum correlation
HSQC
heteronuclear single quantum correlation
LTA
lipoteichoic acid
LTAN2H4
hydrazine-treated LTA (= de-O-acyl-LTA)
ppm
parts/million
LP
lipoprotein
MLST
multilocus sequence typing
RU
repeating unit
TLR
Toll-like receptor
TOCSY
total correlation spectroscopy
IL-6
interleukin-6
TNF
tumor necrosis factor.

References

  • 1. Gottschalk M., Xu J., Calzas C., and Segura M. (2010) Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol. 5, 371–391 10.2217/fmb.10.2 [DOI] [PubMed] [Google Scholar]
  • 2. Gottschalk M., Segura M., and Xu J. (2007) Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim. Health Res. Rev. 8, 29–45 10.1017/S1466252307001247 [DOI] [PubMed] [Google Scholar]
  • 3. Goyette-Desjardins G., Auger J. P., Xu J., Segura M., and Gottschalk M. (2014) Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg. Microbes Infect. 3, e45 10.1038/emi.2014.45 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. King S. J., Leigh J. A., Heath P. J., Luque I., Tarradas C., Dowson C. G., and Whatmore A. M. (2002) Development of a multilocus sequence typing scheme for the pig pathogen Streptococcus suis: identification of virulent clones and potential capsular serotype exchange. J. Clin. Microbiol. 40, 3671–3680 10.1128/JCM.40.10.3671-3680.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Ye C., Bai X., Zhang J., Jing H., Zheng H., Du H., Cui Z., Zhang S., Jin D., Xu Y., Xiong Y., Zhao A., Luo X., Sun Q., Gottschalk M., and Xu J. (2008) Spread of Streptococcus suis sequence type 7, China. Emerg. Infect. Dis. 14, 787–791 10.3201/eid1405.070437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Yu H., Jing H., Chen Z., Zheng H., Zhu X., Wang H., Wang S., Liu L., Zu R., Luo L., Xiang N., Liu H., Liu X., Shu Y., Lee S. S., et al. (2006) Human Streptococcus suis outbreak, Sichuan, China. Emerg. Infect. Dis. 12, 914–920 10.3201/eid1206.051194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Lachance C., Gottschalk M., Gerber P. P., Lemire P., Xu J., and Segura M. (2013) Exacerbated type II interferon response drives hypervirulence and toxic shock by an emergent epidemic strain of Streptococcus suis. Infect. Immun. 81, 1928–1939 10.1128/IAI.01317-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Auger J.-P., Fittipaldi N., Benoit-Biancamano M.-O., Segura M., and Gottschalk M. (2016) Virulence studies of different sequence types and geographical origins of Streptococcus suis serotype 2 in a mouse model of infection. Pathogens 5, E48 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Fittipaldi N., Xu J., Lacouture S., Tharavichitkul P., Osaki M., Sekizaki T., Takamatsu D., and Gottschalk M. (2011) Lineage and virulence of Streptococcus suis serotype 2 isolates from North America. Emerg. Infect. Dis. 17, 2239–2244 10.3201/eid1712.110609 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Fittipaldi N., Sekizaki T., Takamatsu D., Harel J., Domínguez-Punaro M., Von Aulock S., Draing C., Marois C., Kobisch M., and Gottschalk M. (2008) d-Alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis. Infect. Immun. 76, 3587–3594 10.1128/IAI.01568-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Wichgers Schreur P. J., Rebel J. M., Smits M. A., van Putten J. P., and Smith H. E. (2011) Lgt processing is an essential step in Streptococcus suis lipoprotein mediated innate immune activation. PLoS ONE 6, e22299 10.1371/journal.pone.0022299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Hashimoto M., Tawaratsumida K., Kariya H., Kiyohara A., Suda Y., Krikae F., Kirikae T., and Götz F. (2006) Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 177, 3162–3169 10.4049/jimmunol.177.5.3162 [DOI] [PubMed] [Google Scholar]
  • 13. Zähringer U., Lindner B., Inamura S., Heine H., and Alexander C. (2008) TLR2–promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213, 205–224 10.1016/j.imbio.2008.02.005 [DOI] [PubMed] [Google Scholar]
  • 14. Percy M. G., and Gründling A. (2014) Lipoteichoic acid synthesis and function in Gram-positive bacteria. Annu. Rev. Microbiol. 68, 81–100 10.1146/annurev-micro-091213-112949 [DOI] [PubMed] [Google Scholar]
  • 15. Hess N., Waldow F., Kohler T. P., Rohde M., Kreikemeyer B., Gómez-Mejia A., Hain T., Schwudke D., Vollmer W., Hammerschmidt S., and Gisch N. (2017) Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae. Nat. Commun. 8, 2093 10.1038/s41467-017-01720-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Stoll H., Dengjel J., Nerz C., and Götz F. (2005) Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect. Immun. 73, 2411–2423 10.1128/IAI.73.4.2411-2423.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Morath S., Geyer A., and Hartung T. (2001) Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193, 393–397 10.1084/jem.193.3.393 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Gisch N., Schwudke D., Thomsen S., Hess N., Hakenbeck R., and Denapaite D. (2015) Lipoteichoic acid of Streptococcus oralis Uo5: a novel biochemical structure comprising an unusual phosphorylcholine substitution pattern compared to Streptococcus pneumoniae. Sci. Rep. 5, 16718 10.1038/srep16718 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Czabańska A., Neiwert O., Lindner B., Leigh J., Holst O., and Duda K. A. (2012) Structural analysis of the lipoteichoic acids isolated from bovine mastitis Streptococcus uberis 233, Streptococcus dysgalactiae 2023 and Streptococcus agalactiae 0250. Carbohydr. Res. 361, 200–205 10.1016/j.carres.2012.09.007 [DOI] [PubMed] [Google Scholar]
  • 20. Gisch N., Kohler T., Ulmer A. J., Müthing J., Pribyl T., Fischer K., Lindner B., Hammerschmidt S., and Zähringer U. (2013) Structural reevaluation of Streptococcus pneumoniae lipoteichoic acid and new insights into its immunostimulatory potency. J. Biol. Chem. 288, 15654–15667 10.1074/jbc.M112.446963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Lecours M.-P., Gottschalk M., Houde M., Lemire P., Fittipaldi N., and Segura M. (2011) Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. J. Infect. Dis. 204, 919–929 10.1093/infdis/jir415 [DOI] [PubMed] [Google Scholar]
  • 22. Kovacs-Simon A., Titball R. W., and Michell S. L. (2011) Lipoproteins of bacterial pathogens. Infect. Immun. 79, 548–561 10.1128/IAI.00682-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Morr M., Takeuchi O., Akira S., Simon M. M., and Mühlradt P. F. (2002) Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur. J. Immunol. 32, 3337–3347 10.1002/1521-4141(2002012)32:12%3C3337::AID-IMMU3337%3E3.0.CO%3B2-I [DOI] [PubMed] [Google Scholar]
  • 24. Akira S., Uematsu S., and Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell 124, 783–801 10.1016/j.cell.2006.02.015 [DOI] [PubMed] [Google Scholar]
  • 25. Fischer K., Stein K., Ulmer A. J., Lindner B., Heine H., and Holst O. (2011) Cytokine-inducing lipoteichoic acids of the allergy-protective bacterium Lactococcus lactis G121 do not activate via Toll-like receptor 2. Glycobiology 21, 1588–1595 10.1093/glycob/cwr071 [DOI] [PubMed] [Google Scholar]
  • 26. Percy M. G., Karinou E., Webb A. J., and Gründling A. (2016) Identification of a lipoteichoic acid glycosyltransferase enzyme reveals that GW-domain containing proteins can be retained in the cell wall of Listeria monocytogenes in the absence of lipoteichoic acid or its modifications. J. Bacteriol. 198, 2029–2042 10.1128/JB.00116-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Rismondo J., Percy M. G., and Gründling A. (2018) Discovery of genes required for lipoteichoic acid glycosylation predicts two distinct mechanism for wall teichoic acid glycosylation. J. Biol. Chem. 293, 3293–3306 10.1074/jbc.RA117.001614 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Slater J. D., Allen A. G., May J. P., Bolitho S., Lindsay H., and Maskell D. J. (2003) Mutagenesis of Streptococcus equi and Streptococcus suis by transposon Tn917. Vet. Microbiol. 93, 197–206 10.1016/S0378-1135(03)00030-0 [DOI] [PubMed] [Google Scholar]
  • 29. Gottschalk M., Higgins R., Jacques M., and Dubreuil D. (1992) Production and characterization of two Streptococcus suis capsular type 2 mutants. Vet. Microbiol. 30, 59–71 10.1016/0378-1135(92)90094-A [DOI] [PubMed] [Google Scholar]
  • 30. Calzas C., Goyette-Desjardins G., Lemire P., Gagnon F., Lachance C., Van Calsteren M.-R., and Segura M. (2013) Group B Streptococcus and Streptococcus suis capsular polysaccharides induce chemokine production by dendritic cells via Toll-like receptor 2- and MyD88-dependent and -independent pathways. Infect. Immun. 81, 3106–3118 10.1128/IAI.00113-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Roy D., Grenier D., Segura M., Mathieu-Denoncourt A., and Gottschalk M. (2016) Recruitment of factor H to the Streptococcus suis cell surface is multifactorial. Pathogens 5, E47 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Gottlieb H. E., Kotlyar V., and Nudelman A. (1997) NMR chemical shifts of common laboratory solvents as trace impurities. J. Org. Chem. 62, 7512–7515 10.1021/jo971176v [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES